期刊文献+

erbB-2与erbB-3在舌鳞状细胞癌中的表达及临床意义

The Expression and Correlation Analysis of ErbB-2 and ErbB-3 in Tongue Squamous Cell Carcinoma
下载PDF
导出
摘要 目的:探讨erbB-2和erbB-3表达水平与舌鳞状细胞癌发生、发展及预后的关系。方法:免疫组化检测52例舌鳞状细胞癌临床标本中erbB-2和erbB-3蛋白表达情况,研究erbB-2和erbB-3表达情况与舌鳞状细胞癌患者性别、年龄、临床分期、肿瘤大小、病理分级、淋巴转移的相关性。结果:erbB-2在舌鳞状细胞癌临床标本中的阳性表达率为67.3%,erbB-3阳性率为34.6%,erbB-2/erbB-3双阳性率为26.9%。erbB-3、erbB-2/erbB-3阳性表达均与淋巴结转移呈正相关(P=0.031,P=0.002);erbB-2表达与erbB-3表达相关;而erbB-2、erbB-3、erbB-2/erbB-3阳性表达与舌鳞状细胞癌患者性别、年龄、临床分期、肿瘤大小、病理分级无相关性。结论:erbB-2和erbB-3可能均参与了该肿瘤的发生、发展过程;erbB-3、erbB-2/erbB-3阳性表达可能与舌鳞状细胞癌生物学行为、患者淋巴结转移相关。 Objective: This study was to test the expression of erbB-2 and erbB-3 of epithelial growth factor receptor family in clinical specimens of tougue squamous cell carcinoma and to explore the role of expression of erbB-2 and erbB-3 in the carcinogenesis and development of tongue squamous cell carcinoma. Methods:Fifty-two specimens of tongue squamous cell carcinoma were tested with immumohistoehemieal assay. Then the relationship between the expression of erbB-2, erbB-3 and the gender, age of patients, clinical stage, tumor size, pathological grade and lymphatic metastasis were analyzed. Results: The positive expression ratio of erbB-2 and erbB-3 were 67.3% and 34.6%,respectively. 26.9% of tumors were positive stained both by erbB-2 and erbB-3. The expression of erbB-3, erbB-2/erbB-3 were significantly correlated with lymphatic metastasis (P = 0. 031 ,P = 0. 002). And the correlation-ship between erbB-2 and erbB-3 was also found. Conclusion: ErbB-3 and erbB-2 may play important roles in the carcinogenesis and development of tongue squamous cell carcinoma. The positive expression of erhB-3 and erbB-2/erbB-3 were associated with the biological behavior of tumors and lymphatic metastasis of patients.
出处 《中国临床医学》 2009年第3期462-464,共3页 Chinese Journal of Clinical Medicine
基金 上海市科委重点项目(08jc1404800)
关键词 舌鳞状细胞癌 ERBB-2 erbB-3 基因表达 Tongue squamous cell carcinoma ErbB-2 ErbB-3 Gene expression
  • 相关文献

参考文献12

二级参考文献10

  • 1胡勇,饶慧蓉.癌基因c-erbB-2在乳腺癌研究中的进展[J].临床与实验病理学杂志,1993,9(4):298-301. 被引量:23
  • 2倪灿荣.金探针在光镜免疫组织化学中的应用[J].第二军医大学学报,1990,11(1):58-59. 被引量:2
  • 3Hwang I H,J Virol,1984年,50卷,2期,417页 被引量:1
  • 4Xia W,Clin Cancer Res,1997年,3卷,1期,3页 被引量:1
  • 5Shin C,Nature,1981年,290卷,261页 被引量:1
  • 6S. Bosari,G. Viale. The clinical significance of p53 aberrations in human tumours[J] 1995,Virchows Archiv(3):229~241 被引量:1
  • 7Yarden Y,Sliwkowski MX.Untangling the C-erbB-2 signalling network[].Nature Reviews Molecular Cell Biology.2001 被引量:1
  • 8Meric F,Hung MC,Hortobagyi GN,et al.HER2/neu in the management of invasive breast cancer[].Journal of the American College of Surgeons.2002 被引量:1
  • 9Hayes DF,Yamauchi H,Broadwater G,et al.Circulating Her2/neu extracellular domain as a prognostic factor in patients with metastatic breast cancer : cancer and leukemia group B study 8662[].Clinical Cancer Research.2001 被引量:1
  • 10Yamauchi H,Stearns V,Hayes DF.When is a tumor marker ready for prime time ? A case study of C-erbB-2 as a predictive factor in breast cancer[].Journal of Clinical Oncology.2001 被引量:1

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部